MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 28.472

Change

+0.40 (+1.41)%

Market Cap

N/A

Volume

900.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.08 (-0.17%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

+1.28 (+0.65%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.27 (+0.51%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

+1.17 (+1.00%)

USD 19.98B
CGABL The Carlyle Group Inc. 4.625% ..

+0.13 (+0.73%)

USD 16.14B
SNDK Sandisk Corp

+0.83 (+1.51%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 5.17B
NVDL GraniteShares 1.5x Long NVDA D..

-1.58 (-3.34%)

USD 3.76B
ETHA iShares Ethereum Trust ETF

+0.05 (+0.34%)

USD 3.75B
TSLL Direxion Shares ETF Trust - Di..

-0.88 (-9.54%)

USD 3.11B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.96% 87% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.96% 87% B+ 83% B
Trailing 12 Months  
Capital Gain -2.56% 27% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.56% 23% F 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.27% 35% F 38% F
Dividend Return -0.27% 29% F 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.20% 86% B+ 97% N/A
Risk Adjusted Return -8.48% 26% F 29% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.